Marc Salzberg - Concepedia

Author

Marc Salzberg

University Hospital of Basel

Also Known As

E. March, M Salzberg, M. Salzberg, Marc Oliver Salzberg, Marc Salzberg, Roland Greinwald, SE Bucher

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Basel Medpace (United States)Universität Hamburg Ospedale Regionale di Bellinzona e Valli Glycotope (Germany)

About

Marc Salzberg is an author at University Hospital of Basel specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.6K
2	Health Sciences	4	4	1K
3	Cell Biology	2	2	857
4	Biomedical Engineering	1	1	846
5	Cellular Therapies	1	1	11

Marc Salzberg

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors Eilon D. Kirson, Vladimír Dbalý, F Tovaryś, Proceedings of the National Academy of Sciences Tumor InnervationHigh-grade GliomasBiomedical EngineeringGliomaTumor Biology	2007	846
Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer Stephen Chan, M. E. Scheulen, S. Johnston, Journal of Clinical Oncology	2005	468
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects Manuel Haschke, Manfred Schuster, Marko Poglitsch, Clinical Pharmacokinetics HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular Pharmacology	2013	373
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer Christoph Rochlitz, Robert A. Figlin, Patrick Squiban, The Journal of Gene Medicine	2003	172
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer Miklos Pless, C. Droege, Roger von Moos, Lung Cancer Tumor Treating FieldsMedicineBronchial NeoplasmCombined Modality TreatmentPhase I/ii Trial	2013	101
Combining Capecitabine and Gemcitabine in Patients With Advanced Pancreatic Carcinoma: A Phase I/II Trial Viviane Hess, Marc Salzberg, Markus Borner, Journal of Clinical Oncology	2002	95
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas Walter Fiedler, S. DeDosso, Sara Cresta, European Journal of Cancer	2016	71
Survival without Common Toxicity Criteria Grade 3/4 Toxicity for Pemetrexed Compared with Docetaxel in Previously Treated Patients with Advanced Non-small Cell Lung Cancer (NSCLC): A Risk-Benefit Analysis Jean-Louis Pujol, Sofia Paul, Nadia Chouaki, Journal of Thoracic Oncology OncologyRisk-benefit AnalysisMedicineMetronomic TherapyPemetrexed Compared	2007	66
A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid Tumors Marc Salzberg, Eilon D. Kirson, Yoram Palti, Onkologie	2008	66
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma Monika Jermann, Rolf A. Stahel, Marc Salzberg, Cancer Chemotherapy and Pharmacology UrologyRenal-cell CarcinomaPhase IiGenitourinary CancerMedicine	2005	58

Page 1